Merck ChIPAb+ E2F-1 - ChIP Validated Antibody and Primer Set

ChIPAb+ E2F-1 - ChIP Validated Antibody and Primer Set

from mouse

Transcription factor E2F1, Retinoblastoma-binding protein 3, PRB-binding protein E2F-1

Quality Level

100

생물학적 소스

mouse

클론

monoclonal

species reactivity

Xenopus, human

manufacturer/tradename

ChIPAb+
Upstate®

technique(s)

ChIP: suitable (ChIP-seq)
immunoprecipitation (IP): suitable

동형

IgG

NCBI 수납 번호

NP_005216

UniProt 수납 번호

Q01094

배송 상태

dry ice

All ChIPAb+ antibodies are individually validated for chromatin precipitation, every lot, every time. Each ChIPAb+ antibody set includes control primers (tested every lot by qPCR) to biologically validate your IP results in a locus-specific context. The qPCR protocol and primer sequences are provided, allowing researchers to validate ChIP protocols when using our antibody in their chromatin context. Each set also includes a negative control antibody to ensure specificity of the ChIP reaction.
The ChIPAb+ E2F-1 set includes the E2F-1 antibody, a negative control normal mouse IgG, and qPCR primers which amplify a 100 bp region of human CDC2 promoter. The E2F-1 and negative controls are supplied in a scalable per ChIP reaction size and can be used to functionally validate the precipitation of E2F-1-associated chromatin.